<article>
  <type>blog</type>
  <title>Defense Threat Reduction Agency Awards Biomimetic Contract</title>
  <author>George I. Seffers</author>
  <date>March 21, 2013</date>
  <departments>
    <department>Defense Operations</department>
    <department>Acquisition and Contracting</department>
  </departments>
  <tags>
    <tag>VaxDesign Corp.</tag>
    <tag>Defense Threat Reduction Agency</tag>
    <tag>biomimetics</tag>
    <tag>chem-bio</tag>
    <tag>Contract Awards</tag>
  </tags>
  <abstract></abstract>
  <text>Sanofi Pasteur VaxDesign Corporation,Â Orlando, Fla., is being awarded a $15,106,789 cost-plus fixed-fee, incrementally-funded contract for research and development services for the Defense Threat Reduction Agency (DTRA) to further optimize and utilize the invitro biomimetic immune system. The contract award was a direct response to DTRA's Chem-Bio Broad Agency Announcement. The contracting activity is Defense Threat Reduction Agency, Fort Belvoir, Va.</text>
  <imgalttext>
  </imgalttext>
</article>
